Serum Creatinine of 1.1 mg/dL Can Indicate Disease Deterioration and 90‐day Mortality in Hospitalized Patients With Cirrhosis in Chinese Population
Lindan Xie(Sun Yat-sen University), Yubao Zheng(Sun Yat-sen University), Huadong Yan(Zhejiang Shuren University), Wei Yuan(Shanghai Public Health Clinical Center), Guohong Deng(University of Groningen), Xinyi Zhou(Shanghai Medical College of Fudan University), Xiaobo Lu(Xinjiang Medical University), Zhongji Meng(Hubei University of Medicine), Ruochan Chen(Central South University), Yanhang Gao(Jilin University), Yan Huang(First Affiliated Hospital of Chengdu Medical College), Liyuan Long(Central South University), Wenting Tan(Army Medical University), Yixin Hou(Wuhan National Laboratory for Optoelectronics), Beiling Li(Key Laboratory of Guangdong Province), Xin Zheng(Union Hospital), Congcong Zou(Wuhan Union Hospital), Zhiping Qian(Shanghai Public Health Clinical Center), Sen Luo(Hubei University of Medicine), Dandan Wu(University of New Mexico), Jing Li(Second Hospital of Shandong University), Qun Zhang(Beijing Ditan Hospital), Feng Liu(Peking University), Hai Li(Logistics University of People's Armed Police Force), Yuanyuan Chen(Jahra Hospital), Tao Li(Yangtze University), Yan Zhang(Shanghai Jiao Tong University), Yan Xiong(Union Hospital), Wen Gu(University Hospital Münster), Na Gao, Xianbo Wang(Capital Medical University), Jinjun Chen(Southern Medical University), Xiuhua Jiang(Key Laboratory of Guangdong Province), Yu Shi(First Affiliated Hospital Zhejiang University), Jia Shang(European Foundation for the Study of Chronic Liver Failure)
Cited by 0
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
The mechanism of HMGB1 secretion and release
|Experimental & Molecular Medicine|2022|793
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
|The Lancet Oncology|2019|649
Prostate-specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer
|European Urology|2019|464
A functional variant of SUMO4, a new IκBα modifier, is associated with type 1 diabetes
|Nature Genetics|2004|423